• Clinical trial data sharing, including sharing (deidentified) IPD, is rapidly becoming a reality.
• Forward progress in sharing aggregate research results directly with participants (and public.) In 2017, we will anticipate final EMA policy with requirements to post summary results.
• Progress in sharing individual research results. Presenation of Vivaldi, a general access data platform designed to meet global capacity needs.
Link to access full slides and presentaion: www.slideshare.net/petrieflom/barbara-bierer-clinical-trial-data-sharing